Xingxing Zang

Xingxing Zang

Albert Einstein College of Medicine - Bronx / United States
Others
AD Scientific Index ID: 804556
AECOM
person_outline Xingxing Zang's MOST POPULAR ARTICLES
1-) BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1N Watanabe, M Gavrieli, JR Sedy, J Yang, F Fallarino, SK Loftin, ...Nature immunology 4 (7), 670-679, 20039762003
2-) Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathwayKC Ohaegbulam, A Assal, E Lazar-Molnar, Y Yao, X ZangTrends in molecular medicine 21 (1), 24-33, 20156912015
3-) B7x: a widely expressed B7 family member that inhibits T cell activationX Zang, P Loke, J Kim, K Murphy, R Waitz, JP AllisonProceedings of the National Academy of Sciences 100 (18), 10388-10392, 20035102003
4-) Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapyE Picarda, KC Ohaegbulam, X ZangClinical Cancer Research 22 (14), 3425-3431, 20165162016
5-) B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeX Zang, RH Thompson, HA Al-Ahmadie, AM Serio, VE Reuter, ...Proceedings of the National Academy of Sciences 104 (49), 19458-19463, 20074792007